/Investor DB

Saints Capital — 2016 Investments

3 investments dated 2016 · listed companies and verified rows first · show all

Ceroracerora.comin𝕏Mar 2016

Cerora develops biosensor-based neurodiagnostic technology to provide objective, portable data for assessing brain function, with an initial focus on concussion and mild traumatic brain injury.

Digital HealthHealthtechMedical DevicesBethlehem, US

Adam Simon(CEO)in

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Direct Flow MedicalSiftery

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.